An observational study in Aortic Aneurysm, Thoracic and Aortic Dissection, sponsored by University Hospital Padova. Not yet recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-26.
Sponsored by University Hospital Padova · Observational
Multicenter registry on patients treated by the new Gore thoracic branched endoprosthesis
This is a multicenter, non-sponsored, physician-initiated multicenter registry on patients treated with the Gore thoracic branched endoprosthesis.
Inclusion of centers is on a voluntary basis; each participating center includes consecutive patients treated with this device.
131 studies on the registry are indexed under Aortic Aneurysm, Thoracic; 33 are open to participants now.
This study's planned enrollment of 50 is below the median of 154 across 65 observational studies indexed under Aortic Aneurysm, Thoracic.
Browse Aortic Aneurysm, Thoracic studies →University Hospital Padova is the lead sponsor of 41 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All consecutive patients treated with the Gore TAG thoracic branched endograft in the participating centers
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
deployment of the GORE TAG Thoracic Branch Endoprosthesis fro thoraci aorta pathologies
early mortality
mortality related to the intervention within 30 days
Time frame: 30 days
device stability
freedom from related mortality, reintervention, type 1a endoleak during follow-up
Time frame: 5 years
technical success
succesful deployment of all endograft components at the intended site with complete aneurysm exclusion, without surgical conversion, type Ia/III endoleak, kink, stenosis, graft occlusion
Time frame: 30 days
early major adverse events
stroke, spinal cord ischemia, vascular complications, cardiac complications, respiratory insufficiency, early reintervention, acute kidney injury
Time frame: 30 days
Plan to share: Undecided
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital Padova